Brief: Seagen Inc - Decided To Stop Further Development Of Sea-Tgt, Sgn-Alpv And Sgn-Stnv
Nov 1 (Reuters) - Seagen Inc SGEN.O :
* SEAGEN INC - DECIDED TO STOP FURTHER DEVELOPMENT OF
SEA-TGT,
SGN-ALPV AND SGN-STNV
* SEAGEN INC SAYS DECIDED THAT OUR ECHELON-3 ADCETRIS TRIAL
IN
DIFFUSE LARGE B-CELL LYMPHOMA WILL NO LONGER BE CONSIDERED
REGISTRATIONAL - SEC FILING
* SEAGEN INC - HAVE GOAL OF SUBMITTING INDS FOR FOUR NOVEL
DRUG
CANDIDATES IN 2023 BY YEAR END
Source text for Eikon: ID:
Further company coverage: SGEN.O
((Reuters.Briefs@thomsonreuters.com;))